Summary of clinical results

DUCRAY
ANAPHASE Shampooing antichute et antiaffinement 1B

Tolerance and efficacy of ANAPHASE Anti-hair loss and anti-thinning shampoo

Tolerance and efficacy of ANAPHASE anti-hair loss and anti-thinning shampoo in subjects with acute telogen effluvium, under dermatological control.

Population

45 adult women with acute telogen effluvium (proportion of hair in telogen phase ≥ 15%), secondary to a triggering event in the last 2 to 4 months (childbirth, severe stress, febrile state, surgery, diet, fatigue...)

 

ApplicationofANAPHASE Anti-hair loss and anti-thinning shampoo

3 applications per week on the scalp for 12 weeks

 

Evaluation criteria

  • Evaluation of anti-hair loss efficacy (phototrichogram and traction test)
  • Evaluation of visual effect (scoring of hair density on centro-parietal photographs)
  • Self-evaluation questionnaire
  • Skin tolerance under dermatological control

Results

  • After 6 weeks of application, significant 61% increase in the anagen/telogen ratio, confirmed at 12 weeks (+74%).
Anaphase · Évolution de la moyenne du ratio anagène télogène pendant 3 mois
  • Significant reduction in the number of hairs collected in the pull test after 6 weeks of use
  • Significant improvement in hair density on photos at 12 weeks
  • 90% of patients satisfied with volumizing effect at 12 weeks
  • Good skin tolerance
anaphase shampoo
Photographs illustrating the improvement in hair density after 12 weeks' use of ANAPHASE anti-hair loss and anti-thinning shampoo for telogen effluvium.

Conclusion

  • Anti-hair loss efficacy as early as 6 weeks
  • Good skin tolerance